Pediatric cataracts

K W Wright1

  • 1Division of Ophthalmology, Cleveland Clinic Foundation, OH 44195, USA.

Insights

Posterior chamber intraocular lenses are effective for treating aphakia in children over 2 years old. Management of unilateral congenital cataracts is evolving, with part-time occlusion showing promise for better visual outcomes.

Area of Science:

  • Ophthalmology
  • Pediatric ophthalmology

Background:

  • Posterior chamber intraocular lenses (PCIOLs) are standard for aphakia in children aged 2+.
  • Infants typically receive contact lenses due to significant axial eye elongation.
  • Intraocular lens use in juvenile rheumatoid arthritis-associated cataracts is debated, though recent studies show promise.

Purpose of the Study:

  • To review current practices and evolving strategies in pediatric aphakia and cataract management.
  • To discuss the efficacy of intraocular lenses versus contact lenses in pediatric aphakia.
  • To evaluate the changing paradigms in amblyopia management for unilateral congenital cataracts.

Main Methods:

  • Literature review of pediatric intraocular lens implantation and cataract management.
  • Analysis of treatment outcomes for aphakia in children.
  • Examination of evolving amblyopia treatment protocols, including occlusion therapy.

Main Results:

  • PCIOLs are increasingly preferred for aphakia in children over two years old.
  • Part-time occlusion therapy for unilateral congenital cataracts shows improved outcomes compared to historical full-time occlusion.
  • Better development of binocular vision and stereopsis is achievable with updated amblyopia management.

Conclusions:

  • PCIOLs are a viable and often preferred option for pediatric aphakia.
  • Modern amblyopia management, particularly part-time occlusion, offers improved functional vision and reduced strabismus in unilateral congenital cataracts.
  • Continued research is vital for optimizing visual outcomes in challenging pediatric ophthalmic conditions.